Description
Drug Delivery Systems for Metabolic Disorders presents the most recent developments on the targeted delivery of drugs to deal with metabolic disorders in a safe, compliant and continuous way. The book covers recent developments in advanced drug delivery systems in various metabolic disorders, including disturbances in protein, lipid, carbohydrate and hormone metabolism and lysosomal and mitochondrial disorders. It provides a brief introduction to metabolic disorders, along with a focus on the current landscape and trends in understanding disease pathology using different in vitro and in vivo models required for clinical applications and developments of new therapeutics.Each subsequent chapter covers drug delivery systems dedicated to metabolic diseases caused by disturbances in protein, lipid, carbohydrate and hormone metabolism. Then, it moves on to cover lysosomal storage disorders and applications of phytopharmaceuticals in this context. This is the perfect reference for researchers in pharmaceutical science who are interested in developing new treatments for metabolic diseases.- Offers comprehensive coverage of drug delivery to treat metabolic diseases- Provides insights into how advanced drug delivery systems can be effectively used for the management of various types of metabolic disorders- Includes the most recent research on diagnostic methods and treatment strategies using controlled drug delivery systems
Table of Contents
1. Introduction to metabolic disorders2. Cellular and molecular mechanisms involved in metabolic disorders3. Current practices in drug delivery for metabolic disorders4. Recent developments towards treatment of amyloidosis. 5. Advanced drug delivery systems targeting to improve therapeutic outcomes in Porphyria6. Advanced drug delivery systems targeting Kwashiorkor involving disturbance in protein metabo-lism7. Advanced drug delivery systems targeting metabolic disorders involving a disturbance in protein metabolism: Erythropoietic Uroporphyria.8. Combating Atherosclerosis with novel drug delivery approaches: From benchside to commerciali-zation9. Advanced drug delivery systems in the management of Gaucher Disease10. Advanced drug delivery systems focusing the metabolic disorders due to deregulation of lipid me-tabolism: Niemann Pick Disease & Letterer-Siwe disease11. Novel Drug Delivery system to treat Niemann-Pick disease12. Novel 3D printing drug delivery system for the prevention and treatment of Atherosclerosis13. Advanced drug delivery systems to treat Huntington disease: Challenges and opportunities14. Advanced Drug Delivery Systems for obesity 15. Advanced drug delivery systems probing the metabolic disorder due to deregulation in carbohy-drate metabolism16. Advanced drug delivery systems dealing with metabolic disorder due to disturbance in hormone metabolism- hypoglycaemia and hyperglycemia,17. EMERGING drug delivery in the treatment of hyperpituitarism and hypopituitarism18. Advanced drug deliver system dealing with metabolisn disorders due to disturbance in harmone metabolism example Hypoparathyroidism and Hyperparathyroidism19. An update on development of advanced drug delivery systems for treatment of hyperthyroidism20. Advanced drug delivery systems involving lysosomal storage disorders for Schinder disease and other disorders21. Advanced drug delivery systems involving lysosomal storage disorders for Fabry disease22. Drug delivery systems in Krabbe Disease: Present and prospective approaches.23. Advanced Treatment Strategies to combat Tay-Sachs Disease (TSD)24. Sandhoff Disease: Pathology and Advanced Treatment Strategies25. Nanomaterial-based drug delivery approaches for metabolic disorders.26. Eye in Metabolic Disorders: Manifestations and Drug Delivery Systems27. Advanced drug delivery systems involving mitochondrial disorders 28. Application of phytoceuticals in targeting metabolic disorders29. Phytonanoparticles towards the treatment of diabetes. 30. Role of Neutraceuticals in metabolic disorders31. Latest Advances of phytomedicine in drug delivery systems for targeting metabolic disorders.32. Clinical trials, future prospects and challenges of drug delivery in combating metabolic disorders
